posted on 2018-06-07, 08:04authored byRichard J. Hopkinson, Gareth W. Langley, Roman Belle, Louise J. Walport, Kate Dunne, MMartin Münzel, Eidarus Salah, Akane Kawamura, Timothy D. W. Claridge, Christopher J. Schofield
Jumonji domain‐containing demethylases (JmjC‐KDMs) catalyse
demethylation of Nε
‐methylated lysines on histones and play
important rolesin gene regulation. We report selectivity studies on
KDM6B (JMJD3), a disease‐relevant JmjC‐KDM, using synthetic
lysine analogues. The results unexpectedly reveal that KDM6B
accepts multiple Nε
‐alkylated lysine analogues, forming alcohol,
aldehyde and carboxylic acid products.
Funding
We thank the Biotechnology and Biological Sciences Research
Council (BB/J003018/1 and BB/L009846/1), Cancer Research UK
(C8717/A18245), the Systems Approaches to Biomedical
Science Industrial Doctoral Centre (supported by UCB and the
Engineering and Physical Sciences Research Council,
EP/G037280/1, G.W.L), the People Programme (Marie Curie
Actions) of the European Union’s Seventh Framework
Programme (FP7/2007‐2013) under REA grant agreement no.
298603 (Marie Curie IEF Fellowship to M.M), and the Wellcome
Trust (091857/7/10/7) for funding the work. R.J.H
acknowledges a William R. Miller Junior Research Fellowship, St.
Edmund Hall, Oxford, UK. K.D. acknowledges support from the BHF Centre of Research Excellence, Oxford (RE/08/004). We
also acknowledge a Royal Society Dorothy Hodgkin Fellowship
(A.K).
History
Citation
Chemical Communications, 2018, 54, pp. 7975-7978
Author affiliation
/Organisation/COLLEGE OF SCIENCE AND ENGINEERING/Department of Chemistry